News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Antonio P. Legorreta, MD, MPH

Articles by Antonio P. Legorreta, MD, MPH

The Effect of a PPO Pay-for-Performance Program on Patients With Diabetes

ByJudy Y. Chen, MD, MSHS,Haijun Tian, PhD,Deborah Taira Juarez, ScD,Krista A. Hodges, MPH, MBA,Jennifer C. Brand, MPH,Richard S. Chung, MD,Antonio P. Legorreta, MD, MPH

January 1st 2010

A pay-for-performance program in a preferred provider organization setting may significantly increase the receipt of quality care and decrease hospitalization rates among patients with diabetes.

Comparison of Prevalence, Cost, and Outcomes of a Combination of Salmeterol and Fluticasone Therapy to Common Asthma Treatments

ByStephanie W. Wang, PhD,Xiaofeng Liu, MD, PhD,Douglas J. Weiner, MD,Cary Sennett, MD, PhD,Brain W. Bowers, PharmD,Antonio P. Legorreta, MD, MPH

September 1st 2001

Effect of a Comprehensive Nurse-Managed Diabetes Program: An HMO Prospective Study

ByAntonio P. Legorreta, MD, MPH,Anne L Peters, MD,R. Clifford Ossorio, MD,Rosalio J. Lopez, MD,Darius Jatulis, MS,Mayer B. Davidson, MD

September 1st 1996

Latest Updated Articles

Effect of a Comprehensive Nurse-Managed Diabetes Program: An HMO Prospective Study
September 1st 1996
The Effect of a PPO Pay-for-Performance Program on Patients With Diabetes
January 1st 2010
Comparison of Prevalence, Cost, and Outcomes of a Combination of Salmeterol and Fluticasone Therapy to Common Asthma Treatments
September 1st 2001

Trending on AJMC

FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke

How Plans, Clinicians Should Handle Gray-Market Retatrutide

IVF Beats IUI for Early Live Births in Unexplained Infertility

Phase 3 Data Back ALP Normalization as Treatment Goal in PBC

Combination Therapy Expected in Narcolepsy: David T. Plante, MD, PhD